GSK Voluntarily Recalls Acetaminophen OTC Product for Lack of Child-Resistant Packaging
By

GlaxoSmithKline (GSK) Consumer Healthcare is voluntarily recalling all Panadol Advance 100-count caplets pain-relief products from Puerto Rico consumers because the product does not have a child-resistant feature and is not labeled as a product “for households without young children,” reports GSK. The company is working with the US Consumer Products Safety Commission.

Panadol Advance 100-count caplets contains the active ingredient acetaminophen, and thus the bottle requires sealing with a child-resistant feature or to be labeled as a product “for households without young children.” Because the product does not have a child- resistant cap, there is a risk of unintentional ingestion and overdose.

The following lot numbers are being recalled: Lot number: 14241, expiration date: 02/2015; Lot number: 14002, expiration date: 10/2014; Lot number: 13881, expiration date: 09/2014; Lot number: 13801, expiration date: 09/2014

Panadol Advance with Optizorb tablets are used for the relief of headaches, toothache, backache, rheumatic and muscle pains, and period pain. It also relieves the aches and pains of cold and flu, sore throat pain, and helps to reduce temperature.

Source: US Consumer Product Safety Commission and GlaxoSmithKline Consumer Healthcare

Leave a Reply

Your email address will not be published.